Dexcom submits new sensor to FDA, expects summer launch
Dexcom announced that it submitted its new Stelo glucose sensor to the FDA for review at the end of last year.
Stay updated with breaking news from Diego Based Dexcom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dexcom announced that it submitted its new Stelo glucose sensor to the FDA for review at the end of last year.
Dexcom (Nasdaq:DXCM) today unveiled its strategy to expand access to its glucose-sensing technology for millions around the world.
Dexcom (Nasdaq:DXCM) today announced that it intends to offer $1 billion in convertible senior notes due in 2028.
Dexcom announced today that Medicare offers coverage for its beneficiaries using the next-generation G7 CGM.
Dexcom (Nasdaq:DXCM) announced today that the FDA cleared the next-generation Dexcom G7 continuous glucose monitoring (CGM) system.